• Pseudo-UTP (SKU B7972): Reliable RNA Modification for mRNA R

  2026-06-17

  This article delivers scenario-driven, evidence-based insights into how Pseudo-UTP (SKU B7972) addresses key experimental challenges in mRNA synthesis, vaccine development, and gene therapy workflows. By combining product-specific data with published research, it guides biomedical researchers and lab technicians toward reproducible, efficient use of modified uridine triphosphates.

• MG-262 (Z-Leu-Leu-Leu-B(OH)2): Proteasome Inhibition for Mus

  2026-06-16

  Explore how MG-262 (Z-Leu-Leu-Leu-B(OH)2) enables advanced research into proteasome inhibition and muscle protein homeostasis. This article uniquely bridges molecular mechanism, skeletal muscle aging, and practical assay design, offering insights beyond traditional apoptosis and cell cycle studies.

• Cy3 NHS ester (non-sulfonated): Technical Guide & Protocols

  2026-06-16

  Cy3 NHS ester (non-sulfonated) enables reliable, high-sensitivity fluorescent labeling of biomolecules containing amino groups, including proteins, peptides, and oligonucleotides. It is best suited for workflows compatible with organic co-solvents and should not be used for aqueous-only labeling of delicate proteins. Careful adherence to solubility, storage, and handling protocols is essential for reproducible results.

• AAL-993: Advancing Tumor Angiogenesis Research with Precisio

  2026-06-15

  This thought-leadership article examines the mechanistic and strategic value of AAL-993, a potent VEGF receptor inhibitor from APExBIO, for translational researchers tackling tumor angiogenesis and metastasis. Integrating evidence from contemporary network pharmacology studies and highlighting protocol guidance, the article positions AAL-993 as a differentiated tool for high-fidelity angiogenesis inhibition in preclinical models, especially where mechanistic clarity and translational rigor are paramount.

• Sumatriptan as an Anti-Inflammatory: Systematic Review Insig

  2026-06-15

  This systematic review uncovers sumatriptan’s emerging role as an anti-inflammatory agent, extending beyond its classic use for migraine relief. The paper provides evidence that sumatriptan modulates inflammatory pathways, offering potential for broader therapeutic applications and research into neuroimmune mechanisms.

• Continuous Dopaminergic Stimulation with Rotigotine in PD an

  2026-06-14

  The reference paper details the development of the rotigotine transdermal system, a non-ergoline dopamine D2/D3 receptor agonist, for providing continuous dopaminergic stimulation in Parkinson’s disease (PD) and restless legs syndrome (RLS). This innovation addresses limitations of pulsatile oral therapies, improving both motor and non-motor symptom management through sustained drug delivery.

• Applied Workflows with Novobiocin Sodium: DNA & Anti-Parasit

  2026-06-13

  Novobiocin Sodium, a potent aminocoumarin antibiotic from APExBIO, enables precise modulation of DNA replication and anti-parasitic assays. This article distills advanced workflows, highlights the latest anti-Toxoplasma findings, and delivers actionable troubleshooting for metabolic enzyme and antibiotic resistance research.

• Minoxidil Sulphate in Vascular and Hair Growth Research

  2026-06-12

  Minoxidil sulphate, the active metabolite of minoxidil, empowers precision studies in potassium channel biology and hair growth mechanisms. This guide translates recent workflow innovations and troubleshooting strategies into actionable protocols, positioning APExBIO’s high-purity compound as the benchmark for reproducibility in vascular and alopecia research.

• FABP4 Inhibition: Translational Leverage in Atherosclerosis

  2026-06-12

  This thought-leadership article explores the mechanistic and translational potential of BMS 309403—a nanomolar, selective FABP4 inhibitor—in atherosclerosis and cardiometabolic disease research. Integrating new mechanistic insights from recent studies, the article provides actionable protocol guidance, contextualizes BMS 309403 within the competitive landscape, and charts a path for translational researchers seeking to bridge preclinical discovery with clinical impact.

• EZ Cap™ Cy5 EGFP mRNA (5-moUTP): Dual-Fluorescence Delivery

  2026-06-11

  EZ Cap™ Cy5 EGFP mRNA (5-moUTP) redefines transfection assays by enabling real-time, dual-wavelength tracking of both mRNA uptake and translation efficiency. Its immune-evasive Cap 1 structure and 5-moUTP modification empower robust, reproducible gene delivery and functional readouts in advanced cellular models.

• EZH2 Inhibition and 5-Azacytidine Synergize in PTEN-Deficien

  2026-06-11

  This study uncovers a mechanism of immune evasion in PTEN-deficient glioblastoma, showing that combined EZH2 inhibition and 5-Azacytidine treatment reactivates the ERV-MAVS-IFN pathway to enhance antitumor immunity. The findings establish a rationale for epigenetic co-targeting strategies to overcome therapeutic resistance in this aggressive brain cancer.

• Ferroptosis-Gene Signature and Atorvastatin in HCC Prognosis

  2026-06-10

  This study establishes a four-gene ferroptosis-related prognostic signature for hepatocellular carcinoma (HCC) and experimentally identifies atorvastatin as a potential therapeutic agent capable of inducing ferroptosis in HCC cells. The findings provide a rationale for integrating ferroptosis-inducing strategies into HCC research and suggest actionable biomarkers for prognosis.

• Targeting β-Catenin/BCL9 Overcomes Immunotherapy Resistance

  2026-06-10

  The referenced study introduces hydrocarbon-stapled peptide inhibitors that disrupt β-catenin/BCL9 interactions, restoring immune sensitivity in colorectal cancer by modulating regulatory T cell infiltration. This approach represents a novel strategy to potentiate immune checkpoint blockade efficacy, especially in Wnt pathway–driven tumors.

• NLRP10’s Role in Keratinocyte Survival and Barrier Function

  2026-06-09

  This study elucidates how the NLRP10 protein maintains epidermal homeostasis by promoting keratinocyte survival and supporting p63-dependent differentiation, which is essential for skin barrier integrity. The findings provide new mechanistic insight into the genetic risk of atopic dermatitis and highlight NLRP10 as a potential therapeutic target.

• DAPI (hydrochloride): Advanced Workflows in DNA Visualizatio

  2026-06-09

  DAPI (hydrochloride) stands out as a gold-standard DNA stain, enabling high-fidelity chromosome analysis and robust cell cycle studies across fixed and live cell systems. This article delivers proven protocol enhancements, troubleshooting strategies, and actionable insights that help researchers leverage DAPI’s selectivity and fluorescence for next-generation experimental workflows.

446 records 14/30 page Previous Next First page 上5页 1112131415 下5页 Last page